Back in late 2017, I have already pointed out some particular medical cannabis stocks are heavily overvalued, and MXC is definitely not the only one I mentioned.
If you don't believe in someone who has been working in the medical field for more than 10 years, but instead believing in your own sentiment or some unidentified investment "mentors/experts" on HC, then that's your choice, and suffering a substantial loss is a very unfortunate, but likely outcome.
Up to date, MXC's share price have fallen close to 70% from peak, so as other MM stocks that I have mentioned before (can check my last year posts). But I still believe my advice have successfully helped some people avoid such loss.
However, if there are any fundamental changes in the industry, which change my view, I will also let people know asap.
Where is?, page-348
-
- There are more pages in this discussion • 48 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
-0.005(1.75%) |
Mkt cap ! $13.55M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 31.0¢ | 28.0¢ | $1.563K | 5.081K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3025 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 29.0¢ | 1400 | 1 |
View Market Depth
| Last trade - 13.50pm 31/07/2024 (20 minute delay) ? |
| RGT (ASX) Chart |